top of page

Rockefeller Neuroscience Institute’s Marc Haut discusses Alzheimer’s advances at #HLTH2023

  • blonca9
  • Oct 8, 2023
  • 1 min read

Dr. Haut talks about the initial patient demand he is seeing for Leqembi, what it means for the Alzheimer’s field, and opening the blood-brain-barrier to more medicines.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page